Advocates call on the European Commission to make an early pledge of € 715 million to the Global Fund’s replenishment campaign.

Results of a study called into question the recommendation for meropenem with amoxicillin and clavulanate to be used as a second-line therapy for drug-resistant tuberculosis (TB). These findings were published in the American Journal of Respiratory and Critical Care Medicine.

A comment, published in The Lancet Infectious Diseases, reflects on how to achieve global TB control targets through adapting COVID-19 program innovations to enhance access to integrated, patient-centred TB services.

Mumbai (AFP) – When Covid-19 ripped through India in 2020-21, several million people are thought to have died. Desperate efforts to stem the pandemic hurt the battle against another huge killer: tuberculosis.

March 26, 2022: A convoy of five vans snaked slowly on Friday from the battered Ukrainian capital, Kyiv, toward Chernihiv, in the northeast of the country. On board were generators, clothes, fuel — and medications needed to treat H.I.V.

Starting with fair compensation, a meaningful engagement with those who survive the disease will shape effective health services for those who need it the most.

ECDC and WHO/Europe release a joint report providing an overview of the latest TB epidemiological situation in the WHO European Region.

Tuberculosis was the top infectious killer before COVID-19. Yet it never made sensational headlines, and it continues to silently take millions of lives around the world. In 2020 alone, TB killed 1.5 million people, according to the World Health Organization’s latest “Global Tuberculosis Report,” while COVID-19 killed 1.7 million that year.

Executive Summary